ARID1A-driven modulation of EZH2 impedes proliferation and enhances senescence in breast cancer cells
{{output}}
ARID1A mutations, in association with EZH2 overexpression, are linked to various malignancies, particularly those driven by epigenetic dysregulation and associated with therapy resistance. The prevalence of ARID1A mutations is high in ER+ breast cancer, and st... ...
